Constellation, le dépôt institutionnel de l'Université du Québec à Chicoutimi

Identification of OCA2 as a novel locus for the co‐morbidity of asthma‐plus‐eczema

Margaritte‐Jeannin Patricia, Budu‐Aggrey Ashley, Ege Markus, Madore Anne‐Marie, Linhard Christophe, Mohamdi Hamida, von Mutius Erika, Granell Raquel, Demenais Florence, Laprise Catherine, Bouzigon Emmanuelle et Dizier Marie‐Hélène. (2022). Identification of OCA2 as a novel locus for the co‐morbidity of asthma‐plus‐eczema. Clinical & Experimental Allergy, 52, (1), p. 70-81.

[img]
Prévisualisation
PDF - Version acceptée
Disponible sous licence Creative Commons Attribution (CC-BY 2.5).

2MB

URL officielle: http://dx.doi.org/doi:10.1111/cea.13972

Résumé

Background: Numerous genes have been associated with the three most common allergic diseases (asthma, allergic rhinitis or eczema) but these genes explain only a part of the heritability. In the vast majority of genetic studies, complex phenotypes such as co- morbidity of two of these diseases, have not been considered. This may partly explain missing heritability.

Objective: To identify genetic variants specifically associated with the co-morbidity of asthma-plus-eczema.

Methods: We first conducted a meta-analysis of four GWAS (Genome-Wide Association Study) of the combined asthma-plus-eczema phenotype (total of 8807 European-ancestry subjects of whom 1208 subjects had both asthma and eczema). To assess whether the association with SNP(s) was specific to the co- morbidity, we also conducted a meta-analysis of homogeneity test of association according to disease status (“asthma-plus-eczema” vs. the presence of only one disease “asthma only or eczema only”). We then used a joint test by combining the two test statistics from the co-morbidity-SNP association and the phenotypic heterogeneity of SNP effect meta-analyses.

Results: Seven SNPs were detected for specific association to the asthma-plus-eczema co-morbidity, two with significant and five with suggestive evidence using the joint test after correction for multiple testing. The two significant SNPs are located in the OCA2 gene (Oculocutaneous Albinism II), a new locus never detected for significant evidence of association with any allergic disease. This gene is a promising candidate gene, because of its link to skin and lung diseases, and to epithelial barrier and immune mechanisms.

Conclusion: Our study underlines the importance of studying sub-phenotypes as co-morbidities to detect new susceptibility genes.

Type de document:Article publié dans une revue avec comité d'évaluation
ISSN:0954-7894
Volume:52
Numéro:1
Pages:p. 70-81
Version évaluée par les pairs:Oui
Date:2022
Identifiant unique:10.1111/cea.13972
Sujets:Sciences de la santé > Sciences médicales > Génétique
Département, module, service et unité de recherche:Départements et modules > Département des sciences fondamentales
Mots-clés:ALSPAC, asthma, co-morbidity, eczema, EGEA, GABRIELA, GWAS, phenotypic heterogeneity, Saguenay−Lac-Saint-Jean (SLSJ)
Déposé le:09 mai 2022 17:22
Dernière modification:09 mai 2022 17:22
Afficher les statistiques de telechargements

Éditer le document (administrateurs uniquement)

Creative Commons LicenseSauf indication contraire, les documents archivés dans Constellation sont rendus disponibles selon les termes de la licence Creative Commons "Paternité, pas d'utilisation commerciale, pas de modification" 2.5 Canada.

Bibliothèque Paul-Émile-Boulet, UQAC
555, boulevard de l'Université
Chicoutimi (Québec)  CANADA G7H 2B1
418 545-5011, poste 5630